Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Seoul National University Hospital
Seoul National University Hospital
HonorHealth Research Institute
Albert Einstein College of Medicine
Immutep S.A.S.
University of Birmingham
National Cancer Institute (NCI)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Novartis
University of Chicago
AstraZeneca
University of Nebraska
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Zimmer Biomet
Novartis
Washington University School of Medicine
Ferring Ventures Limited
University of Alabama at Birmingham
Mayo Clinic
Children's Hospital Medical Center, Cincinnati
Janssen Research & Development, LLC
Pfizer
"Oncostar" LLC
University of Georgia
Sensome
AstraZeneca
Montefiore Medical Center
Children's Hospital Medical Center, Cincinnati
Ipsen
University of Rochester
Benfovir AG
Sanofi
Beth Israel Deaconess Medical Center
Stanford University
St. Jude Children's Research Hospital
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Imperial College London
Thomas Jefferson University
Institut Cancerologie de l'Ouest
Medical College of Wisconsin
Wake Forest University Health Sciences
Merck Sharp & Dohme LLC
Pfizer
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Institute for Clinical and Experimental Medicine
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)